S. 1674 (111th): Improving Access to Clinical Trials Act of 2009

Overview

Introduced:

Sep 15, 2009
111th Congress, 2009–2010

Status:

Enacted — Signed by the President on Oct 5, 2010

This bill was enacted after being signed by the President on October 5, 2010.

Law:

Pub.L. 111-255

Sponsor:

Ron Wyden

Senator from Oregon

Democrat

Text:

Read Text »
Last Updated: Sep 24, 2010
Length: 3 pages

About the bill

Full Title

A bill to provide for an exclusion under the Supplemental Security Income program and the Medicaid program for compensation provided to individuals who participate in clinical trials for rare diseases or conditions.

Read CRS Summary >

History

Sep 15, 2009
 
Introduced

This is the first step in the legislative process.

Aug 5, 2010
 
Passed Senate

The bill was passed in a vote in the Senate. It goes to the House next. The vote was by Unanimous Consent so no record of individual votes was made.

Sep 23, 2010
 
Passed House

The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill. The vote was by voice vote so no record of individual votes was made.

Oct 5, 2010
 
Enacted — Signed by the President

The President signed the bill and it became law.

This page is about a bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Links & tools

Primary Source

Congress.gov

Congress.gov is updated generally one day after events occur. Legislative activity since the last update may not be reflected on GovTrack. Data via congress project.

Citation

Click a format for a citation suggestion: